MedPath

山西阳和医药技术有限公司

Ownership
-
Established
2019-05-06
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Ambroxol Hydrochloride Solution for Inhalation

Product Name
吸入用盐酸氨溴索溶液
Approval Number
国药准字H20254424
Approval Date
Jun 3, 2025
NMPA

Levosalbutamol Hydrochloride Nebuliser Solution

Product Name
盐酸左沙丁胺醇雾化吸入溶液
Approval Number
国药准字H20253610
Approval Date
Mar 11, 2025
NMPA

Levosalbutamol Hydrochloride Nebuliser Solution

Product Name
盐酸左沙丁胺醇雾化吸入溶液
Approval Number
国药准字H20253611
Approval Date
Mar 11, 2025
NMPA

Peramivir Injection

Product Name
帕拉米韦注射液
Approval Number
国药准字H20249584
Approval Date
Dec 1, 2024
NMPA

Gabexate Mesylate for Injection

Product Name
注射用甲磺酸加贝酯
Approval Number
国药准字H20084323
Approval Date
Dec 7, 2022
NMPA

Cefotiam Hydrochloride for Injection

Product Name
注射用盐酸头孢替安
Approval Number
国药准字H20213316
Approval Date
Apr 27, 2021
NMPA

Vitamin C Injection

Product Name
维生素C注射液
Approval Number
国药准字H53020631
Approval Date
Sep 10, 2020
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H53021551
Approval Date
Sep 10, 2020
NMPA

Vitamin C Injection

Product Name
维生素C注射液
Approval Number
国药准字H53020633
Approval Date
Sep 10, 2020
NMPA

Vitamin C Injection

Product Name
维生素C注射液
Approval Number
国药准字H53020632
Approval Date
Sep 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.